Jiali (Shenzhen) Biotechnology Co., Ltd.

Primary objective: To evaluate the efficacy of CPL-01 compared to placebo in subjects undergoing bunionectomy Secondary objective: To evaluate the efficacy of CPL-01 compared to an active comparator in the study population

This study is a randomized, double-blind, placebo- and active-controlled Phase III study designed to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of CPL-01 for postoperative analgesia after open inguinal hernia mesh repair compared with placebo and ropivacaine hydrochloride (Naropine® or equivalent generic drug). In addition, this study also includes a China-specific open-label PK sub-study.